Head-to-head · Cost-Efficiency Index
Iron Med RX vs Joey Med
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Iron Med RX
Shoppers who want one telehealth account covering GLP-1 plus peptides/hormone care and are comfortable with less pricing/compliance transparency.
Visit Iron Med RXJoey Med
Shoppers who want to pick a molecule-agnostic 'Core / Plus Core' tier and pay per 4, 8, or 12 weeks rather than a recurring monthly subscription.
Visit Joey MedThe verdict
Iron Med RX and Joey Med tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with Iron Med RX (ranked #355, a hair above #356) — Shoppers who want one telehealth account covering GLP-1 plus peptides/hormone care and are comfortable with less pricing/compliance transparency. But Joey Med is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Iron Med RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Iron Med RX | Joey Med |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | $149/mo (compounded) | $199/mo (promotional rate, compounded) |
| Tirzepatide / mo | $149/mo (compounded) | $275/mo (promotional rate, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $2,388 |
| Tirzepatide / yr (modeled) | $1,788 | $3,300 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #355 | #356 |
Iron Med RX
54/100Where the value is
- Low advertised entry price ($149) with free shipping
- No insurance required to start
- Multiple health verticals (peptides, NAD+, men's/women's health) under one account
The tradeoffs
- No drug-specific (semaglutide vs tirzepatide) pricing published -- the $149 figure is a vague floor
- No named medical director or compounding pharmacy partner disclosed
Joey Med
54/100Where the value is
- The site's own embedded pricing data is fully itemized by tier (4/8/12 weeks) for all three products
- Molecule names are disclosed on the category page even though individual product pages use branded tier names
- Legal entity is disclosed via the site's own structured data: MD Telehealth Platform LLC DBA Joey Med
The tradeoffs
- The current roster's prices were stale: $279 was the crossed-out list price for semaglutide (actual: $199), and $399 belonged to the High Dose tirzepatide tier, not the standard $275 entry tier
- Drug names are buried under branded tier names on the product pages themselves
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.